Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Free Cash Flow Generation Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Free Cash Flow Generation Index of 0.16x as of December 2025. Free cash flow of TL22.91 Million represents 0% of operating cash flow (TL140.82 Million). See Meditera Tibbi Malzeme Sanayi ve Ticaret working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. Explore Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year Free Cash Flow Generation Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For the full company profile including market capitalisation, see MEDTR company net worth.
| Year | FCG Index | Free Cash Flow (TRY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | TL243.68 Million | TL435.35 Million | TL191.67 Million | ▼ -15.5% |
| 2024 | 0.66x | TL517.17 Million | TL780.69 Million | TL263.52 Million | ▲ +5.8% |
| 2023 | 0.63x | TL501.32 Million | TL801.02 Million | TL299.70 Million | ▲ +106.8% |
| 2022 | -9.19x | TL-46.87 Million | TL5.10 Million | TL51.35 Million | ▼ -1328.3% |
| 2021 | 0.75x | TL27.42 Million | TL36.64 Million | TL8.92 Million | ▲ +73.2% |
| 2020 | 0.43x | TL31.65 Million | TL73.26 Million | TL20.85 Million | ▼ -56.8% |
| 2019 | 1.00x | TL20.01 Million | TL20.01 Million | TL0.00 | ▲ +0.0% |
| 2018 | 1.00x | TL73.26 Million | TL73.26 Million | TL0.00 | — |